Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
BMC Cancer ; 20(1): 915, 2020 Sep 24.
Artigo em Inglês | MEDLINE | ID: mdl-32972413

RESUMO

BACKGROUND: Multiple myeloma (MM) is an incurable hematological tumor, which is closely related to hypoxic bone marrow microenvironment. However, the underlying mechanisms are still far from fully understood. We took integrated bioinformatics analysis with expression profile GSE110113 downloaded from National Center for Biotechnology Information-Gene Expression Omnibus (NCBI-GEO) database, and screened out major histocompatibility complex, class II, DP alpha 1 (HLA-DPA1) as a hub gene related to hypoxia in MM. METHODS: Differentially expressed genes (DEGs) were filtrated with R package "limma". Gene Ontology (GO) enrichment and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway were performed using "clusterProfiler" package in R. Then, protein-protein interaction (PPI) network was established. Hub genes were screened out according to Maximal Clique Centrality (MCC). PrognoScan evaluated all the significant hub genes for survival analysis. ScanGEO was used for visualization of gene expression in different clinical studies. P and Cox p value < 0.05 was considered to be statistical significance. RESULTS: HLA-DPA1 was finally picked out as a hub gene in MM related to hypoxia. MM patients with down-regulated expression of HLA-DPA1 has statistically significantly shorter disease specific survival (DSS) (COX p = 0.005411). Based on the clinical data of GSE47552 dataset, HLA-DPA1 expression showed significantly lower in MM patients than that in healthy donors (HDs) (p = 0.017). CONCLUSION: We identified HLA-DPA1 as a hub gene in MM related to hypoxia. HLA-DPA1 down-regulated expression was associated with MM patients' poor outcome. Further functional and mechanistic studies are need to investigate HLA-DPA1 as potential therapeutic target.


Assuntos
Cadeias alfa de HLA-DP/genética , Mieloma Múltiplo/genética , Regulação para Baixo , Cadeias alfa de HLA-DP/biossíntese , Cadeias alfa de HLA-DP/imunologia , Cadeias alfa de HLA-DP/metabolismo , Humanos , Mieloma Múltiplo/imunologia , Mieloma Múltiplo/metabolismo , Mieloma Múltiplo/patologia , Prognóstico , Análise de Sobrevida
2.
PLoS One ; 13(10): e0205557, 2018.
Artigo em Inglês | MEDLINE | ID: mdl-30379846

RESUMO

The MHC class II region in humans is highly polymorphic. Each MHC molecule is formed by an α and a ß chain, produced by different genes, creating an antigen-binding groove. In the groove there are several pockets into which antigens anchor and fit. The affinity of this fitting determines the recognition specificity of a given peptide. Here, based on our previous results about the association of MHC class II with the WNV disease, we examined the role of the binding pockets of HLA-DPA1, -DQA1 and-DRB1 in the severe form of the disease. In HLA-DQA1, variants in all pockets 1, 6 and 9 were found to be associated with either protection and/or susceptibility to neuroinvasion caused by WNV. Similarly, pockets 7, 9 and 10 in HLA-DRB1 were associated with severe disease. Protein modeling of these molecules revealed structural and functional differences among alleles with opposite roles concerning the development of the disease. Different amino acids in positions α52 and α66 (HLA-DQA1) significantly influenced the peptide binding while DYWLR/EFA combination (HLA-DRB1) was associated with neuronal damage. Further studies could help us understand the selectivity of pocket variants in order to create suitable peptides for an effective response.


Assuntos
Resistência à Doença/genética , Predisposição Genética para Doença , Cadeias alfa de HLA-DP/genética , Cadeias alfa de HLA-DQ/genética , Cadeias HLA-DRB1/genética , Febre do Nilo Ocidental/genética , Motivos de Aminoácidos , Sequência de Aminoácidos , Sítios de Ligação , Estudos de Coortes , Éxons , Estudos de Associação Genética , Cadeias alfa de HLA-DP/metabolismo , Cadeias alfa de HLA-DQ/metabolismo , Cadeias HLA-DRB1/metabolismo , Humanos , Ligação de Hidrogênio , Modelos Moleculares , Índice de Gravidade de Doença , Febre do Nilo Ocidental/metabolismo
3.
J Biol Chem ; 289(2): 639-53, 2014 Jan 10.
Artigo em Inglês | MEDLINE | ID: mdl-24214983

RESUMO

HLA class II α and ß chains form receptors for antigen presentation to CD4(+) T cells. Numerous pairings of class II α and ß subunits from the wide range of haplotypes and isotypes may form, but most of these combinations, in particular those produced by isotype mixing, yielded mismatched dimers. It is unclear how selection of functional receptors is achieved. At the atomic level, it is not known which interactions of class II residues regulate selection of matched αß heterodimers and the evolutionary origin of matched isotype mixed dimer formation. In this study we investigated assembly of isotype-mixed HLA class II α and ß heterodimers. Assembly and carbohydrate maturation of various HLA-class II isotype-mixed α and ß subunits was dependent on the groove binding section of the invariant chain (Ii). By mutation of polymorphic DPß sequences, we identified two motifs, Lys-69 and GGPM-(84-87), that are engaged in Ii-dependent assembly of DPß with DRα. We identified five members of a family of DPß chains containing Lys-69 and GGPM 84-87, which assemble with DRα. The Lys/GGPM motif is present in the DPß sequence of the Neanderthal genome, and this ancient sequence is related to the human allele DPB1*0401. By site-directed mutagenesis, we inspected Neanderthal amino acid residues that differ from the DPB1*0401 allele and aimed to determine whether matched heterodimers are formed by assembly of DPß mutants with DRα. Because the *0401 allele is rare in the sub-Saharan population but frequent in the European population, it may have arisen in modern humans by admixture with Neanderthals in Europe.


Assuntos
Evolução Molecular , Antígenos HLA-DP/genética , Antígenos HLA-DR/genética , Immunoblotting , Mutação , Sequência de Aminoácidos , Animais , Antígenos de Diferenciação de Linfócitos B/química , Antígenos de Diferenciação de Linfócitos B/genética , Antígenos de Diferenciação de Linfócitos B/metabolismo , Sítios de Ligação/genética , Células COS , Linhagem Celular , Chlorocebus aethiops , Antígenos HLA-DP/química , Antígenos HLA-DP/metabolismo , Cadeias alfa de HLA-DP/química , Cadeias alfa de HLA-DP/genética , Cadeias alfa de HLA-DP/metabolismo , Cadeias beta de HLA-DP/química , Cadeias beta de HLA-DP/genética , Cadeias beta de HLA-DP/metabolismo , Antígenos HLA-DR/química , Antígenos HLA-DR/metabolismo , Cadeias alfa de HLA-DR/química , Cadeias alfa de HLA-DR/genética , Cadeias alfa de HLA-DR/metabolismo , Cadeias beta de HLA-DR/química , Cadeias beta de HLA-DR/genética , Cadeias beta de HLA-DR/metabolismo , Antígenos de Histocompatibilidade Classe II/química , Antígenos de Histocompatibilidade Classe II/genética , Antígenos de Histocompatibilidade Classe II/metabolismo , Humanos , Modelos Moleculares , Homem de Neandertal , Ligação Proteica , Multimerização Proteica , Estrutura Terciária de Proteína
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...